0 comments on “MODEL-AD Presentations at the 2018 Society for Neuroscience Meeting”

MODEL-AD Presentations at the 2018 Society for Neuroscience Meeting

Monday, November 5, 1:30pm – 4pm
Session 345: Global Efforts to Build More Predictive Animal Models of Neurodegenerative Disease
Chair: Bruce T. Lamb, PhD, Indiana University School of Medicine
Co-Chair: Rudolph E. Tanzi, PhD, Massachusetts General Hospital, Harvard Medical School
Location: SDCC 6B 2:45-3:20PM
345.04 Bruce Lamb: Novel insights into Alzheimer’s disease through the MODEL-AD consortium

Nanosymposium 267: Alzheimer’s Disease: Neuroinflammation and Immune Actions
Location: SDCC 24
10:15-10:30 267.10 Kristen Onos: Genetic diversity is a significant driver of amyloid-induced neuroinflammation and neurodegeneration in APP/PS1 mice

Tuesday November 6
Poster Session 466: Alzheimer’s Disease and Other Dementias: Genetic Analysis and Omics Approaches
Systems biology-based method to identify and prioritize Alzheimer’s disease candidate driver genes
S. Mukherjee, T. M. Perumal, K. Daily, S. Sieberts, L. Omberg, C. Preuss, G. Carter, L. Mangravite, B. Logsdon
Board F23, #462.20 presented 11:00-12:00am

Poster Session 467: Alzheimer’s Disease and Other Dementias: Therapeutic Strategies: Preclinical Animal Models II
Novel models of late-onset Alzheimer’s disease
Mike Sasner for the MODEL-AD Center   Sasner SfN 2018 GWAS poster final
Board G8, #467.01 presented 8:00-9:00am

hAb-KI: A knock-in mouse model for sporadic Alzheimer’s disease
Stefania Forner for the MODEL-AD Center
Board G9, #467.02, presented 9:00-10:00am

MODEL-AD: Late-onset Alzheimer’s disease models
Adrian Oblak for the MODEL-AD Center   Oblak OverviewFINAL
Board G10, #467.03 presented 10:00-11:00am

Preclinical screening strategy of the MODEL-AD consortium: Evaluation of the pharmacokinetics and pharmacodynamics of treatment with Levetiracetam
Stacey Rizzo for the MODEL-AD Center   Rizzo et al SfN PTC MODELAD Poster – 20181029 vPRT_sjsr_FINAL
Board G11, #467.04 presented 11:00am-noon

Translational genetic and genomic analyses of new mouse models of Alzheimer’s disease
Greg Carter for the MODEL-AD Center   Carter_SFN_2018
Board G12, #467.05 presented 8:00-9:00am

MODEL-AD: Standardized characterization of familial Alzheimer’s disease models (5xFAD, 3Tg-AD, APP/PS1, and hTau)
Gareth Howell for the MODEL-AD Center   Howell FAD SfN MODEL-AD poster
Board G13, #467.06 presented 9:00-10:00am

Wednesday, November 7, 1:00 PM – 3:15 PM
Nanosymposium 713: Alzheimer’s Disease and Other Dementias: Abeta: Pathologic Mechanisms
Location: SDCC 33

1:45-2:00 713.04 David Baglietto-Vargas hAb-KI mice: A novel tool for investigating risk factors in sporadic Alzheimer’s cases





0 comments on “The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.”

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.

A recent publication from the lab of Christian Haass has shown altered splicing of mouse Trem2 that is dependent upon the presence of the R47H mutation and leads to a cryptic splice site in exon 2 and a deletion of 119 nucleotides.

The MODEL-AD project has similar data demonstrating the cryptic splice site.  We are currently using Western blots and whole-brain transcriptomic analysis to assay mutant protein levels.  For now, we argue that the conclusion that “functional data derived from Trem2*R47H knock-in mice cannot be translated to humans” put forward in this paper may be premature because full-length transcripts are generated in Trem2*R47H homozygotes, albeit at reduced levels.

In parallel, we are considering alternative strategies to create Trem2 alleles to model late-onset AD.

AlzForum story

Article in PubMed

0 comments on “MODEL-AD presentations at AAIC 2018”

MODEL-AD presentations at AAIC 2018

Sunday July 22
Poster P1-130  Familial Models_OBLAK_AAIC 2018 -min
MODEL-AD: Characterization of Familial AD Models (5xFAD, APP/PS1, hTau, 3xTg-AD)

Poster P1-131  MODEL AD overview-min (1)
MODEL-AD: Late-Onset Alzheimer’s Disease Models

Haβ-KI: A Knock-in Mouse Model for Sporadic Alzheimer’s Disease
Room – 184
8:45am – 9:00am

Monday July 23
Room 183
New In Vivo Models for Alzheimer’s Disease – MODEL-AD

Poster P2-045
The MODEL-AD Consortium Preclinical Testing Pipeline: Pharmacokinetics and Pharmacodynamics of Prophylactic Treatment with Leviteracetam in the 5XFAD Mouse Model of Alzheimer’s Disease

Tuesday July 24
Room 184
Systems Biology Ranking of Candidate Alzheimer’s Driver Genes Identifies New Genetic Drivers of Alzheimer’s

Wednesday July 25
Room 185
Whole-Exome Analysis of Late-Onset Alzheimer’s Disease Reveals Novel Candidate Genes Involved in Cognitive Function

Poster P4-028  APOE4 trem2 model (1)_sjsr edits(2) GRH v2-min
Characterizing the APOE4/Trem2*R47H Mouse Model for Late Onset Alzheimer’s Disease

Poster P4-031  AAIC GWAS models poster PDF-min
Novel Models of Late-Onset Alzheimer’s Disease Based on GWAS

Poster P4-045
Biological Pathways and Related Protein Biomarkers of Clinical Progression in Early Alzheimer’s Disease

0 comments on “MODEL-AD presentations at ICMN”

MODEL-AD presentations at ICMN

Monday June 11



GWAS-based mouse models exhibit distinct transcriptomic signatures of late-onset Alzheimer’s disease

Greg Carter (The Jackson Laboratory, USA)


Tuesday June 12



Unraveling the Role of Innate Immune Pathways in Neurodegeneration

Bruce Lamb (Indiana University, USA)


Tuesday June 12

Poster P2-K14

Model Organism Development and Evaluation for Late-onset Alzheimer’s Disease: MODEL-AD

Harriet Williams (The Jackson Laboratory, USA)

0 comments on “Indiana U. Alzheimer’s symposium”

Indiana U. Alzheimer’s symposium

The IU/JAX MODEL-AD Center and the Indiana Alzheimer’s Disease Center hosted a scientific symposium focusing on translational approaches to Alzheimer’s disease featuring speakers from the Stark Neurosciences Institute, The Jackson Lab, Sage Bionetworks and Eli Lilly as well as a poster session.

Thanks to sponsors: Alzheimer Association; Stark Neurosciences Research Institute; IU Alzheimer’s Disease Center; and Indiana Clinical and Translational Sciences Institute.


IU symposium group shot

0 comments on “Workshop on the use of mouse models to study neurodegenerative disease”

Workshop on the use of mouse models to study neurodegenerative disease

The Jackson Laboratory will present the 3rd annual Workshop on using mouse models to study human neurodegenerative disease in May.  This course will focus on the use of the innovative tools and methods, specifically in the laboratory mouse, for answering questions of neuron and circuit function and disease mechanisms during neurodegeneration.  The course will employ both didactic and hands-on instruction in both laboratory techniques and bioinformatics.

Workshop details

0 comments on “Center Manager position available”

Center Manager position available

The Model Organism Development and Evaluation for Late-onset-Alzheimer’s Disease (MODEL-AD) project seeks a Center Manager for the Jackson Lab site in Bar Harbor, Maine.  MODEL-AD aims to create the next generation of mouse models for AD and develop new therapeutic targets. The Center Manager is an integral team member in this multi-project, multi-institutional grant.  The successful candidate will devote effort to managing the laboratory staff, overseeing mouse colony management, data production and analyses, and presenting research updates at internal and external meetings.  Administrative responsibilities include serving as liaison between investigators at JAX, Indiana University (IU), and University of California-Irvine (UCI), communications between JAX MODEL-AD project leaders, and managing documentation for data use and lab and animal protocols. The successful candidate will be able to apply for grants to develop their own research interests that leverage the resources being developed within MODEL-AD.


More information and how to apply.